Wells Fargo & Company »

Aptevo Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Aptevo Therapeutics shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Aptevo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aptevo Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aptevo Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $292 1.6k 0.18
2023-09-30 $515 1.6k 0.33
2023-06-30 $2.2k 1.5k 1.46
2022-12-31 $3.7k 1.6k 2.32
2022-09-30 $0 1.8k 0.00
2022-06-30 $0 1.6k 0.00
2022-03-31 $0 1.6k 0.00
2021-12-31 $0 1.6k 0.00
2021-09-30 $31k 1.6k 20.00
2021-06-30 $54k 1.6k 34.48
2021-03-31 $47k 1.6k 30.18
2020-12-31 $58k 1.6k 37.04
2020-09-30 $0 455 0.00
2020-06-30 $0 450 0.00
2020-03-31 $0 25 0.00